Literature DB >> 22306102

Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia.

Weidong Xie1, Yunan Zhao, Lijun Du.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Traditional Chinese medicine (TCM) formulas have been widely used in China since ancient times to treat certain diseases (e.g., phlegm, dampness and blood stasis). Recently, the effects of these medicines have been increasingly demonstrated to be helpful for hyperlipidemic patients. AIM OF THE STUDY: This manuscript aims to describe the scientific evidence for the efficacy of TCM and attempts to identify potential TCM formulas for treating hyperlipidemia.
MATERIALS AND METHODS: TCM formulas approved by the State Food and Drug Administration of China (SFDA) were sourced from the official SFDA website (http://www.sda.gov.cn/). Human and animal evidence for the hypolipidemic effects of herbs from TCM formulas were reviewed via the Internet (Elsevier, ACS, Wiley Online Library, SpringerLink, PubMed, Web of Science, CNKI, Baidu, and Google) and libraries up to October 31, 2011.
RESULTS: More than 50 TCM formulas have been used to treat hyperlipidemia. These herbs can primarily be grouped into three categories: (1) herbs promoting excretions, generally by reducing food retention, enhancing purgative effects, and promoting diuresis and choleretic effects, e.g., Fructus Crataegi (), Radix Polygoni Multiflori (), Semen Cassiae (), and Radix et Rhizoma Rhei (), Rhizoma alismatis (), and Herba Artemisiae Scopariae (); (2) herbs acting on the cardiovascular system, generally by improving blood circulation based on TCM theories, e.g., Radix Salviae Miltiorrhizae (), Radix Puerariae (), Rhizoma Chuanxiong (), Flos Carthami (), and Folium Nelumbinis (); and (3) herbs that have tonic effects, e.g., Fructus Lycii (), Radix Ginseng (), and Radix Astragali ().
CONCLUSIONS: Three basic approaches, including excretory function enhancement, cardiovascular system improvement, and tonic effect reinforcement, are emerging among TCM formulas for the treatment of hyperlipidemia. These approaches may be useful in controlling blood lipid levels, preventing cardiovascular complications, and adjusting bodily functions in hyperlipidemic patients. However, solid evidence of the efficacy of these treatments is required.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306102     DOI: 10.1016/j.jep.2012.01.027

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  31 in total

Review 1.  Traditional Chinese medicine for lipid metabolism disorders.

Authors:  Yiping Li; Xiaolong Wang; Zhijie Shen
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

2.  Effect of Hedan Tablets on Body Weight and Insulin Resistance in Patients with Metabolic Syndrome.

Authors:  Lian-Yong Liu; Lin Zhou; Xing-Zhen Liu; Da-Jin Zou
Journal:  Obes Facts       Date:  2021-12-30       Impact factor: 4.807

3.  Effects of berberine and cinnamic acid on palmitic acid-induced intracellular triglyceride accumulation in NIT-1 pancreatic β cells.

Authors:  Li Zhao; Shu-Jun Jiang; Fu-Er Lu; Li-Jun Xu; Xin Zou; Kai-Fu Wang; Hui Dong
Journal:  Chin J Integr Med       Date:  2014-12-09       Impact factor: 1.978

4.  Tissue distribution model and pharmacokinetics of nuciferine based on UPLC-MS/MS and BP-ANN.

Authors:  Yanyan Xu; Shihui Bao; Weiqiang Tian; Congcong Wen; Lufeng Hu; Chongliang Lin
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 5.  Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compounds.

Authors:  Guy-Armel Bounda; Y U Feng
Journal:  Pharmacognosy Res       Date:  2015 Jul-Sep

Review 6.  Chinese herbal medicine on dyslipidemia: progress and perspective.

Authors:  Ming Guo; Yue Liu; Zhu-Ye Gao; Da-Zhuo Shi
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-13       Impact factor: 2.629

7.  Inhibition of LXRα/SREBP-1c-Mediated Hepatic Steatosis by Jiang-Zhi Granule.

Authors:  Miao Wang; Shanshan Sun; Tao Wu; Li Zhang; Haiyan Song; Weiwei Hao; Peiyong Zheng; Lianjun Xing; Guang Ji
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-16       Impact factor: 2.629

8.  ACE Reduces Metabolic Abnormalities in a High-Fat Diet Mouse Model.

Authors:  Seong-Jong Lee; Jong-Min Han; Jin-Seok Lee; Chang-Gue Son; Hwi-Jin Im; Hyun-Kyung Jo; Ho-Ryong Yoo; Yoon-Sik Kim; In-Chan Seol
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-05       Impact factor: 2.629

9.  Impact of Community-Based Integrated Traditional Chinese and Western Medicine Metabolic Syndrome Intervention Technology in Rural Residents in Southern Jiangsu, China.

Authors:  Yuqing Wang; Bo Xie; Yanghong Tao; Yonghua Ma; Kaijin Zhang
Journal:  Med Sci Monit       Date:  2015-07-26

10.  Evaluation of a crataegus-based multiherb formula for dyslipidemia: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Miao Hu; Weiwei Zeng; Brian Tomlinson
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.